Miller Derek 4
4 · AMGEN INC · Filed May 9, 2024
Insider Transaction Report
Form 4
AMGEN INCAMGN
Miller Derek
SVP, Human Resources
Transactions
- Award
Common Stock
2024-05-07+865→ 8,983 total - Award
Nqso (Right to Buy)
2024-05-07$300.30/sh+5,624$1,688,887→ 11,248 totalExercise: $300.30From: 2026-05-07Exp: 2034-05-07→ Common Stock (5,624 underlying)
Footnotes (4)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2026 and 5/7/2028, respectively.
- [F2]These shares include the following Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Equity Incentive Plan: 134 RSUs which will vest on 4/30/2025; 581 RSUs which will vest in installments of 286 on 5/2/2025, and 295 on 5/2/2026; 1,101 RSUs which will vest in two installments of 363 each on 5/2/2025 and 5/2/2026, and 375 on 5/2/2027; and 865 RSUs which will vest in two installments of 285 on 5/7/2026 and on 5/7/2027, and one installment of 295 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F3]These shares include 92 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- [F4]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.